[1]贺小红.18F-FDG正电子显像质量保证[J].国际放射医学核医学杂志,2004,28(5):193-196.
　HE Xiao-hong.Quality assurance of 18F-FDG positron imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):193-196.
点击复制

18F-FDG正电子显像质量保证(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
28
期数:
2004年第5期
页码:
193-196
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Quality assurance of 18F-FDG positron imaging
作者:
贺小红
528000 广东佛山, 广东省佛山市第一人民医院核医学科
Author(s):
HE Xiao-hong
Department of Nuclear Medicine, The First People’s Hospital of Foshan, Foshan 528000, China
关键词:
18F-氟代脱氧葡萄糖; 质量保证; 质量控制; 正电子显像
Keywords:
18F-fluorodeoxyglucose; quality assurance; quality control; positron imaging
分类号:
R817.4
摘要:
18F-FDG(18F-氟代脱氧葡萄糖)正电子显像(包括传统的PET和符合线路显像)的重要价值已为大量临床研究所证实,但其结果的影响因素比较复杂。本文就仪器验收和日常质量控制、检查前准备、数据采集和处理,以及结果分析等方面,介绍18F-FDG正电子显像的质量保证措施。
Abstract:
The value of 18F-FDG imaging with dual-head gamma camera has been demonstrated by a large number of clinical studies. For 18F-FDG coincidence imaging, however, effective factors are various from the patient’s preparation to the results interpreted. The purpose of this paper was to outline the quality assurance procedures for this kind of imaging. Six items were included, such as acceptance testing and daily quality control of the imaging instruments, patients interviewing, 18F-FDG injection, data acquisition, data processing and results interpreter. After reading this paper, the readers should be awaked to the careful consideration of executing a coincidence imaging.

参考文献/References:

1 IAEA-TECDOC-602,Quality Control of Nuclear Medicine Instruments[S].
2 NEMA Standards Publication NU 2-2001,Performance Measurements of Positron Emission Tomographs.National Electrical Manufacturers Association[S].
3 NEMA Standards Publication NU 1-2001,Performance Measurements of Scintillation Cameras.National Electrical Manufacturers Association[S].
4 Interenational Electrotechnical Commission (IEC)61675-1,Rodi-onuelide imaging devices-daracteristics and test conditions part 1:Positro emission tomographs[S].
5 Tatsumi M,Clark PA,Nakamoto Y,et al.Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET[J],Eur J Nucl Med Mol Imag,2003,30(1):40-45.
6 Lartizien C,Comtat C,Kinahan PE,et al.Optimization of injected dose based on noise equivalent count rates for 2-and 3-dimensional whole-body PET[J].J Nucl Med,2002,43(9):1268-1278.
7 Kubota K,Itoh M,Ozaki K,et al.Advantage of delayed whole-body FdG PET imaging for tumour detection[J].Eur J Nucl Med,2001,28(6):696-703.
8 Demura Y,Tsuchida T,Ishizaki T,et al.18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax[J].J Nucl Med,2003,44(4):540-548.
9 Boerner AR,Weckesser M,Herzog H,et al.Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer[J].Eur J Nucl Med,1999,26(3):226-230.
10 Kadrmas DJ,Christian PE.Comparative evaluation of lesion detectability for 6 PET imaging platforms using a highly reproducible whole-body phantom with (22)Na lesions and localization ROC analysis[J].J Nucl Med,2002,43(11):1545-1554.
11 Bettinardi V,Pagani E,Gilardi MC.Implementation and evaluation of a 3D one-step late reconstruction algorithm for 3D positron emission tomography brain studies using median root prior[J].Eur J Nucl Med Mol Imag,2002,29(1):7-18.
12 Lartizien C,Kinahan PE,Swensson R,et al.Evaluating image reconstruction methods for tumor detection in 3-dimensional whole-body PET oncology imaging[J].J Nucl Med,2003,44(2):276-290.
13 Zaidi H.Reconstruction-based estimation of the scatter component in positron emission tomography[J].Ann Nucl Med Sci,2001,14:161-172.
14 Ak I,Blokland JA,Pauwels EK,et al.The clinical valve of 18F-FDG detection with a dual-head coincidence camera:a review[J].Eur J Nucl Med,2001,28(6):763-778.
15 Zaidi H,Hasegawa B.Determination of the attenuation map in emission tomography[J].J Nucl Med,2003,44(2):291-315.
16 Nakamoto Y,Osman M,Cohade C,et al.PET/CT:comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images[J].J Nucl Med,2002,43(9):1137-1143.
17 Osman MM,Cohade C,Nakamoto Y,et al.Clinically significant inaccurate localization of lesions with PET/CT:frequency in 300 patients[J].J Nucl Med,2003,44(2):240-243.
18 Beyer T,Townsend DW,Brun T,et al.A conbined PET/CT scanner for clinical oncology[J].J Nucl Med,2000,41:1369-1379.
19 Goerres GW,Kamel E,Heidelberg TN,et al.PET-CT image coregistration in the thorax:influence of respiration[J].Eur J Nucl Med Mol Imag,2002,29(3):351-360.
20 Giraud P,Grahek D,Montravers F,et al.CT and (18)F-deoxyglu-cose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers[J].Int J Radiat Oncol Biol Phys,2001,49(5):1249-1257.
21 Karger CP,Hipp P,Henze M,et al.Stereotactic imaging for radiotherapy:accuracy of CT,MRI,PET and SPECT[J].Phys Med Biol,2003,48(2):211-221.

相似文献/References:

[1]江波,刘振宅,徐晓.调强放疗中有关多叶准直器的质量保证与质量控制[J].国际放射医学核医学杂志,2006,30(6):378.
　JIANG Bo,LIU Zhen-zhai,XU Xiao.Quality assurance and quality control of multileaf collimator in intensity modulated radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):378.
[2]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):10.
[3]陈香,赵军.PET-CT在非小细胞肺癌中的应用[J].国际放射医学核医学杂志,2005,29(3):97.
　CHEN Xiang,ZHAO Jun.The application value of PET-CT imaging in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):97.
[4]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):197.
[5]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):201.
[6]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):205.
[7]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):209.
[8]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):213.
[9]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):216.
[10]黄建敏,付占立,潘莉萍.18F-FDG代谢显像标准摄取值的影响因素[J].国际放射医学核医学杂志,2004,28(1):3.
　HUANG Jian-min,FU Zhan-li,PAN Li-ping.Affect factors of the standardized uptake value for metabolic imaging with 18F-fluorine-2-deoxy-D-glucose[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):3.

备注/Memo

备注/Memo:
收稿日期:2003-12-30。
更新日期/Last Update: 1900-01-01